Filing Details

Accession Number:
0000950170-25-042777
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-20 17:21:52
Reporting Period:
2025-03-18
Filing Date:
2025-03-20
Accepted Time:
2025-03-20 17:21:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1768446 Climb Bio Inc. CLYM Pharmaceutical Preparations (2834) 832273741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1969365 Emily Pimblett C/O Climb Bio, Inc.
20 William Street, Suite 145
Wellesley Hills MA 02481
Svp, Finance & Cao No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-18 5,000 $0.00 16,329 No 4 M Direct
Common Stock Disposition 2025-03-20 1,199 $1.31 15,130 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2025-03-18 5,000 $0.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
  2. The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.31 to $1.325, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  5. The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.